29 results
424B3
PTPI
Petros Pharmaceuticals Inc
19 Sep 23
Prospectus supplement
4:36pm
, as amended (the “Sarbanes–Oxley Act”);
reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements … and registration statements; and
exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval
POS AM
otu9caxpuoj viv
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
PRE 14A
7j38qlub0 d9jda589j5
30 Sep 22
Preliminary proxy
4:45pm
424B3
byb4vo
14 Jan 22
Prospectus supplement
5:18pm
424B5
chumm 1wle9aryg4uh
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B3
blb3vw5r
20 Dec 21
Prospectus supplement
7:24am
424B5
auq535
1 Dec 21
Prospectus supplement for primary offering
5:10pm
424B3
hoaj0zmx38 oarx4hma
23 Nov 21
Prospectus supplement
4:11pm
DEF 14A
uvc vqaem
22 Nov 21
Definitive proxy
4:37pm